As of Jun 22
| +1.20 / +2.22%|
The 19 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 58.00, with a high estimate of 70.00 and a low estimate of 45.00. The median estimate represents a +5.19% increase from the last price of 55.14.
The current consensus among 22 polled investment analysts is to Hold stock in Bristol-Myers Squibb Co. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.